CoChat

Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke

Open access
Zhong, Chongke, Yang, Jingyuan, Xu, Tan, Xu, Tian, Peng, Yanbo, Wang, Aili, Wang, Jinchao, Peng, Hao, Li, Qunwei, Ju, Zhong, Geng, Deqin, Zhang, Yonghong, He, Jiang, For the CATIS Investigators, CATIS Investigators, He, Jiang, Zhang, Yonghong, Xu, Tan, Wang, Dali, Peng, Yanbo, Wang, Jinchao, Ju, Zhong, Li, Qunwei, Geng, Deqin, Zhang, Jintao, Li, Dong, Zhang, Fengshan, Guo, Libing, Sun, Yingxian, Wang, Xuemei, Cui, Yong, Li, Yongqiu, Ma, Dihui, Zhang, Dongsheng, Yang, Guang, Gao, Yanjun, Zhao, Liang, Yuan, Xiaodong, Han, Xiujie, Zhang, Mingyu, Duan, Shurong, Feng, Tao, Li, Jizhen, Liu, Suzhen, Hu, Wei, Nie, Chun, Zhao, Nuenjiya · 2017 · Neurology
Cited by 164

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Objective: To examine the association between serum matrix metalloproteinases-9 (MMP-9) levels and prognosis of acute ischemic stroke. Methods: We measured serum MMP-9 levels in 3,186 participants (2,008 men and 1,178 women) from the China Antihypertensive Trial in Acute Ischemic Stroke (CATIS). Study outcome data on death, major disability (modified Rankin Scale score ≥3), and vascular disease were collected at 3 months after stroke onset. Results: During 3 months of follow-up, 767 participants (24.6%) experienced major disability or died. Serum MMP-9 was significantly associated with an increased risk of death and major disability after adjustment for age, sex, time from onset to randomization, current smoking, alcohol drinking, admission NIH Stroke Scale score, diastolic blood pressure, plasma glucose, white blood cell counts, use of antihypertensive medications, and history of hypertension, coronary heart disease, and diabetes mellitus. For example, 1-SD (0.32 ng/mL) higher log–MMP-9 was associated with an odds ratio (95% confidence interval) of 1.16 (1.06–1.28) for the combined outcome of death and major disability, 1.12 (1.01–1.23) for major disability, and 1.29 (1.01–1.66) for death. The addition of serum MMP-9 to conventional risk factors improved risk prediction of the combined outcome of death or major disability (net reclassification index 9.1%, p = 0.033; integrated discrimination improvement 0.4%, p = 0.004). Conclusions: Higher serum MMP-9 levels in the acute phase of ischemic stroke were associated with increased risk of mortality and major disability, suggesting that serum MMP-9 could be an important prognostic factor for ischemic stroke.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000004257

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 164

Metadata

Authors
Zhong, C., Yang, J., Xu, T., Xu, T., Peng, Y., Wang, A., Wang, J., Peng, H., Li, Q., Ju, Z., Geng, D., Zhang, Y., He, J., For the CATIS Investigators, CATIS Investigators, He, J., Zhang, Y., Xu, T., Wang, D., Peng, Y., Wang, J., Ju, Z., Li, Q., Geng, D., Zhang, J., Li, D., Zhang, F., Guo, L., Sun, Y., Wang, X., Cui, Y., Li, Y., Ma, D., Zhang, D., Yang, G., Gao, Y., Zhao, L., Yuan, X., Han, X., Zhang, M., Duan, S., Feng, T., Li, J., Liu, S., Hu, W., Nie, C., & Zhao, N.
Venue
Neurology
Published
2017-08-22
Volume
89
Issue
8
Pages
805-812
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2738997953
Cited by
164
References
3
FWCI
5.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke. https://app.cochat.ai/papers/10.1212/wnl.0000000000004257
The paper
Zhong, C., Yang, J., Xu, T., Xu, T., Peng, Y., Wang, A., Wang, J., Peng, H., Li, Q., Ju, Z., Geng, D., Zhang, Y., He, J., For the CATIS Investigators, CATIS Investigators, He, J., Zhang, Y., Xu, T., Wang, D., . . . Zhao, N. (2017). Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke. Neurology. https://doi.org/10.1212/wnl.0000000000004257

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.